Home
>
National Drug Code (NDC)
>
Liothyronine Sodium
Liothyronine Sodium - 43063-252-30 - (Liothyronine Sodium)
Drug Information of Liothyronine Sodium
| Product NDC: | 43063-252 |
| Proprietary Name: | Liothyronine Sodium |
| Non Proprietary Name: | Liothyronine Sodium |
| Active Ingredient(s): | 50 ug/1 & nbsp; Liothyronine Sodium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Liothyronine Sodium
| Product NDC: | 43063-252 |
| Labeler Name: | PD-Rx Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090097 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20090323 |
Package Information of Liothyronine Sodium
| Package NDC: | 43063-252-30 |
| Package Description: | 30 TABLET in 1 BOTTLE, PLASTIC (43063-252-30) |
NDC Information of Liothyronine Sodium
| NDC Code | 43063-252-30 |
| Proprietary Name | Liothyronine Sodium |
| Package Description | 30 TABLET in 1 BOTTLE, PLASTIC (43063-252-30) |
| Product NDC | 43063-252 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Liothyronine Sodium |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20090323 |
| Marketing Category Name | ANDA |
| Labeler Name | PD-Rx Pharmaceuticals, Inc. |
| Substance Name | LIOTHYRONINE SODIUM |
| Strength Number | 50 |
| Strength Unit | ug/1 |
| Pharmaceutical Classes | l-Triiodothyronine [EPC],Triiodothyronine [Chemical/Ingredient] |
